Stay updated with breaking news from Conformis daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Stock Performance CFMS stock opened at $2.26 on Monday. The company has a market cap of $17.80 million, a P/E ratio […] ....
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Stock Performance Shares of NASDAQ CFMS opened at $2.26 on Friday. The business has a 50 day simple moving average of $2.25 […] ....
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note published on Saturday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Conformis Price Performance Shares of NASDAQ:CFMS opened at $2.26 on Friday. The company has a current ratio of 5.07, a quick ratio of 3.30 […] ....
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Conformis Price Performance Shares of NASDAQ CFMS opened at $2.26 on Friday. Conformis has a 52 week low of $1.05 and a 52 week high […] ....
StockNews.com initiated coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Get Our […] ....